# AJENAT PHARMACEUTICALS LLC – FDA Inspection, Aug 16, 2024

Source: https://www.keypedia.com/records/fda_inspections/ajenat-pharmaceuticals-llc/86e0a09f-9bb7-4cf0-abf3-8d05e39fb85f
Source feed: FDA_Inspections

> FDA inspection 1246567 of AJENAT PHARMACEUTICALS LLC, August 16, 2024. Classification: Voluntary Action Indicated (VAI). 8 citations under 21 CFR part 211. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1246567
- Company Name: AJENAT PHARMACEUTICALS LLC
- Inspection Date: 2024-08-16
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 8

## Related Documents

- [FDA Inspection 1337342 - 2026-09-24](https://www.keypedia.com/records/fda_inspections/ajenat-pharmaceuticals-llc/9f4d267e-4b2a-4a82-83fb-97eb23fdbc30)
- FDA Inspection 1262754 - 2025-02-07
- FDA Inspection 1093582 - 2019-05-24
- [FDA Inspection 1042674 - 2018-03-01](https://www.keypedia.com/records/fda_inspections/ajenat-pharmaceuticals-llc/a681b8c1-6120-4644-ae9f-f1593be5e93d)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/jessica-p-mcalister/d892c069-d283-4bb0-9cbb-78e463bfc1ea)
- [FDA Associated Person](https://www.keypedia.com/people/kayla-v-sprague/154cb543-111b-4ad1-b45b-43900df71b90)

Company: https://www.keypedia.com/companies/ajenat-pharmaceuticals-llc/3971f2cf-98dc-49ad-9450-088c02ebc568

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c